Alaunos Therapeutics News

Alaunos Therapeutics | 8-K: Current report

Oct 10 20:34

Alaunos Therapeutics | 8-K/A: Current report (Amendment)

Jul 18 01:04

Alaunos Therapeutics | 8-K/A: Current report (Amendment)

Jul 18 01:04

Alaunos Therapeutics | 8-K: Current report

Jul 16 21:07

Alaunos Therapeutics | 8-K: Current report

Jul 16 21:02

Alaunos Therapeutics | 8-K: Current report

Jun 22 05:06

Alaunos Therapeutics | 8-K: Current report

Jun 13 05:03

Alaunos Therapeutics | DEFA14A: Others

Apr 27 04:54

Alaunos Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:51

Alaunos Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 05:25

Alaunos Therapeutics | 8-K: Current report

Feb 23 05:49

Alaunos Therapeutics | 8-K: Current report

Feb 21 05:10

Alaunos Therapeutics | 8-K: Current report

Feb 2 01:17

Alaunos Therapeutics | 8-K: Current report

Jan 29 21:48

Alaunos Therapeutics | 8-K: Current report

Jan 22 13:00

Alaunos Therapeutics | 8-K: Current report

Jan 2 13:00

Alaunos Therapeutics | 8-K: Current report

Dec 28, 2023 13:00

Alaunos Therapeutics | 8-K: Current report

Dec 22, 2023 21:00

Alaunos Therapeutics | 8-K: Current report

Nov 15, 2023 20:30

Alaunos Therapeutics | 8-K: Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Nov 14, 2023 20:40